Page 311 - Chiral Separation Techniques
P. 311

12.3 Advantages of SFC for Chiral Separations  303

             higher in SFC, and analysis times were shorter compared to LC. They also explored
             the influence of the type of modifier on selectivity in SFC.
               Mourier’s report was quickly followed by successful enantiomeric resolutions on
             stationary phases bearing other types of chiral selectors, including native and deriva-
             tized cyclodextrins and derivatized polysaccharides. Many chiral compounds of
             pharmaceutical interest have now been resolved by packed column SFC, including
             antimalarials, β-blockers, and antivirals. A summary is provided in Table 12-2. Most
             of the applications have utilized modified CO as the eluent.
                                                    2
             Table 12-2. Selected applications of chiral SFC to pharmaceutical compounds . a
             Chiral stationary phase      Compounds resolved

             Cellulose derivatives        β-Blockers, benzodiazepines, NSAIDs, barbiturates
             Amylose derivatives          NSAIDs, protease inhibitors, β-blockers, benzodiazepines
             Brush-type                   Antimalarials, NSAIDs, β-blockers, bronchodilators
             Cyclodextrins and derivatives  Phosphine oxides, NSAIDs, anticonvulsants
             Macrocyclic antibiotics      Bronchodilators, β-blockers
             a  For a more comprehensive listing, see. ref. [12].






















             Fig. 12-1. Separation of primaquine enantiomers on a Chiralcel OD CSP. Chromatographic conditions:
                                                                –1
             20 % methanol with 0.5 % isopropylamine in carbon dioxide, 2.0 mL min , 15 MPa, 30 °C.

               Some of the initial enthusiasm surrounding chiral SFC was tempered by the fact
             that many of the same separations had already been achieved by LC [29]. Therefore,
             researchers were reluctant to add SFC to their analytical laboratories. In some
             instances, SFC does yield separations that can not be achieved on the same CSP in
             LC [30, 31]. The enantioseparation of primaquine, an antimalarial compound, on a
             Chiralcel OD CSP is illustrated in Fig. 12-1 [32]. This compound was not resolved
             on the same CSP in LC [33]. The reverse situation, where a separation obtained in
             LC may not be observed on the same CSP in SFC, can also occur [34]. These dis-
             parities seem to be related to differences in analyte-eluent and eluent-CSP interac-
   306   307   308   309   310   311   312   313   314   315   316